Finances: Page 2
-
CVS plans to exit ACA individual exchanges, strikes Wegovy deal with Novo Nordisk
Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish drugmaker Novo Nordisk that should expand access to its in-demand GLP-1 at the expense of Eli Lilly’s.
By Rebecca Pifer • May 1, 2025 -
GE Healthcare slashes 2025 profit forecast on tariff impact
CFO Jay Saccaro said the company is looking at strategies to mitigate the impact of tariffs, including more dual sourcing and making products where they are consumed.
By Susan Kelly • April 30, 2025 -
Tenet will stay the course on M&A, despite turbulence in Washington
Executives said uncertainties about tariffs and Medicaid have not altered the health system’s core priority to grow its ambulatory services business.
By Susanna Vogel • April 30, 2025 -
Supreme Court rules against hospitals in DSH formula case
“The hospitals have lost at every stage of this litigation,” Justice Amy Coney Barrett wrote in the court’s majority opinion.
By Emily Olsen • April 30, 2025 -
Humana posts ‘really good’ first quarter on stable medical costs
Despite the outperformance, the payer’s stock was largely flat following the earnings release — a market reaction that reflects the uncertainty facing Humana.
By Rebecca Pifer • April 30, 2025 -
UHS sees behavioral health volumes drop in Q1
The health system maintained its guidance for the full year and said it could turn around performance in its behavioral health segment.
By Susanna Vogel • April 29, 2025 -
HCA grows revenue in Q1, reaffirms 2025 outlook
Although HCA beat the street’s expectations for profit in the first quarter, analysts said reaffirming its guidance is a “prudent” move given possible headwinds from Washington.
By Susanna Vogel • April 28, 2025 -
Sponsored by Cedar Gate Technologies
The secrets to success with bundled payments in healthcare
Bundled payment models are growing in healthcare. Here is the blueprint for success.
April 28, 2025 -
Centene raises outlook for revenue — and costs — in 2025
Centene’s first-quarter results didn’t appear to quell investor concerns about volatility in the health insurance market.
By Rebecca Pifer • Updated April 25, 2025 -
CHS emphasizes divestitures, strong volumes in Q1 earnings
The Franklin, Tennessee-based system continued to deleverage its portfolio during the quarter, boosted volumes and “held the line” on supply expenses, CEO Tim Hingtgen said.
By Susanna Vogel • April 24, 2025 -
Molina reports mixed Q1, says Medicaid rates are increasing
The California-based insurer’s results were “good enough,” one analyst said.
By Rebecca Pifer • April 24, 2025 -
Elevance brushes off fears of spiking Medicare Advantage costs
Investors balked last week after UnitedHealth reported first-quarter MA utilization grew at twice its expected rate. Yet Elevance said spending was in line with expectations, a development one analyst called surprising.
By Rebecca Pifer • April 22, 2025 -
UnitedHealth posts ‘unacceptable’ first quarter, slashes 2025 guidance
The healthcare juggernaut’s results came in unusually below Wall Street’s expectations and caused its stock to plummet Thursday. The development bodes ill for the rest of the managed care sector, analysts said.
By Rebecca Pifer • April 17, 2025 -
US launches probe that could set stage for pharma tariffs
The Commerce Department has begun a so-called Section 232 investigation into the national security effects of the U.S. importing pharmaceuticals and their starting materials.
By Ned Pagliarulo • Updated April 14, 2025 -
Medicare proposes 2.4% pay hike for inpatient hospitals next year
The rate increase is the lowest since 2019. The American Hospital Association slammed it as inadequate.
By Rebecca Pifer • April 14, 2025 -
Late-stage digital health funding rebounds in Q1: Rock Health
The median deal size for late-stage funding rounds was $105 million, nearly double the $55 million check size across 2024.
By Emily Olsen • April 9, 2025 -
Walgreens shrinks losses as Sycamore take-private deal nears
Walgreens also withdrew its 2025 financial guidance, citing the pending take-private deal, which is expected to close by the end of the year.
By Rebecca Pifer • April 8, 2025 -
CVS taps former UPS finance chief as new CFO
Brian Newman will guide CVS’ finances at a challenging time for the retail pharmacy and health insurance giant. Still, CVS also said on Tuesday it could exceed previously issued guidance in 2025.
By Emily Olsen • April 8, 2025 -
UnitedHealth shareholders withdraw effort to force transparency on coverage denials
The faith-based shareholders’ proposal was challenged by UnitedHealth twice, thanks to a recent SEC guidance change the shareholders slammed as unfair. They could still reintroduce it next year.
By Rebecca Pifer • April 7, 2025 -
More Americans say they can’t afford healthcare: Gallup
Roughly 29 million people, or 11% of those surveyed, said they were unable to afford medication and care within the past three months.
By Susanna Vogel • April 4, 2025 -
Margins improve at nonprofit hospitals in 2024, but headwinds loom: Fitch
The median operating margin for providers that ended their fiscal years early was 1.2% last year, compared with -0.5% in 2023. However, potential Medicaid cuts could strain provider finances.
By Emily Olsen • March 31, 2025 -
Solventum cuts 800 positions
CEO Bryan Hanson told investors last week that the restructuring plan would save the medical supply and health IT company $120 million annually.
By Ricky Zipp • March 26, 2025 -
Sponsored by RxSense
The future of pharmacy benefits: The shift to insourcing PBM services
The pharmacy benefit landscape is shifting. With rising costs, limited transparency, and rigid structures imposed by legacy pharmacy benefit managers (PBMs), organizations are considering a bold move—bringing their PBM operations in-house.
March 24, 2025 -
Optum Rx is reforming how it pays pharmacies
The massive PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid. Pharmacy groups say that depends on the specifics of Optum Rx’s plan.
By Rebecca Pifer • March 21, 2025 -
Veradigm releases long-awaited financial results
The health IT vendor hadn’t filed quarterly or annual reports since November 2022. Veradigm was delisted from Nasdaq for failing to comply with financial reporting requirements last year.
By Emily Olsen • March 20, 2025